[LUM#9] An Introduction to Interferon
A virologist at the Montpellier Institute for Infectious Disease Research (IRIM), Caroline Goujon has been leading a research team studying interferon since 2015. Interferon is a molecule secreted by our cells that is essential for fighting off pathogens, yet its mechanism of action remains poorly understood.
Her journey with interferon began nearly ten years ago in the United Kingdom. Caroline Goujon was then pursuing postdoctoral research following an exemplary—and almost novelistic—career path that took her from a vocational diploma tothe Cochin Institute. There, she worked alongside “passionatelecturers who loved sharing their knowledge and really set me on the right path.” It was a golden opportunity, as the following year she enrolled at the École Normale Supérieure de Lyon before heading to England.
Fascinated by viruses and “their ability to hijack the entire cellular machinery for their own benefit,” she specialized in HIV until she made this unexpected discovery: “I stumbled upon some fascinating data while conducting experiments. That’s when I became interested in the effect of interferon on host cells.”
Through various experiences
Upon returning to France seven years later, she passed the competitive exam to become a research fellow, secured funding for young researchers, and assembled her own team to study interferon. It must be said that interferon has everything it takes to inspire passion. A natural antiviral, this molecule secreted by our cells has the incredible power to protect us against viruses and bacteria without relying on antibodies. How does it work?
Produced by the cell when a pathogen invades, interferon binds to the cell’s surface as well as to those of surrounding cells and sends out an alarm signal that triggers genetic reprogramming in each of them.“These cells exposed to interferon will express about a hundred genes, a handful of which will encode proteins capable of fighting the infection,” the biologist notes.
A race against time
Here’s the theory:“In real life, it’s a race against time, ”explains Caroline Goujon. “A virus like the flu multiplies very quickly. Interferon helps limit its spread, but it’s not enough.” As a result , we get sick.
Hence the interest among scientistsin “identifying this handful of genes capable of inhibiting viral replication”in order to better understand how they work. The ultimate goal isthe “distant hope” of paving the way for new therapies. In “the unique atmosphere of[ her] confined laboratory, and the calm”—so deeply appreciated—of a one-on-one encounter between virus and interferon, the researcher knows: “Potentially, the solution lies within us.”
UM podcasts are now available on your favorite platform (Spotify, Deezer, Apple Podcasts, Amazon Music, etc.).